These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3355791

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J, Luo M, Cheng P, Liao L, Deng X, Deng D, Lin F.
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
    Furlan M, Bögli C, Hofer A, Bouvier CA, de Moerloose P.
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
    [Abstract] [Full Text] [Related]

  • 25. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M, Baba M, Morimoto K, Nakamikawa C.
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [Abstract] [Full Text] [Related]

  • 26. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA, Southan C, Ireland H, Thompson E, Kehl M, Henschen A.
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [Abstract] [Full Text] [Related]

  • 27. Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family.
    Linenberger ML, Kindelan J, Bennett RL, Reiner AP, Côté HC.
    Am J Hematol; 2000 Aug; 64(4):242-50. PubMed ID: 10911375
    [Abstract] [Full Text] [Related]

  • 28. Fibrinogen Chapel Hill: hypodysfibrinogenemia with a tertiary polymerization defect.
    McDonagh RP, Carrell NA, Roberts HR, Blatt PM, McDonagh J.
    Am J Hematol; 1980 Aug; 9(1):23-38. PubMed ID: 7435499
    [Abstract] [Full Text] [Related]

  • 29. Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
    Zhou J, Ding Q, Wu W, Ouyang Q, Xie Y, Wu X, Lu Y, Dai J, Liang Q, Wang H, Wang X, Hu Y.
    J Clin Pathol; 2017 Feb; 70(2):145-153. PubMed ID: 27555433
    [Abstract] [Full Text] [Related]

  • 30. Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A.
    Reber P, Furlan M, Beck EA, Barbui T.
    Thromb Res; 1987 Apr 01; 46(1):163-7. PubMed ID: 3590111
    [No Abstract] [Full Text] [Related]

  • 31. Acquired dysfibrinogenaemia in acute and chronic liver disease.
    Lane DA, Scully MF, Thomas DP, Kakkar VV, Woolf IL, Williams R.
    Br J Haematol; 1977 Feb 01; 35(2):301-8. PubMed ID: 870000
    [Abstract] [Full Text] [Related]

  • 32. Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.
    Wilde JT, Thomas WE, Lane DA, Greaves M, Preston FE.
    J Clin Pathol; 1988 Jun 01; 41(6):615-8. PubMed ID: 3384995
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hereditary dysfibrinogenemia.
    Bithell TC.
    Clin Chem; 1985 Apr 01; 31(4):509-16. PubMed ID: 3978780
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K, Terasawa F, Okumura N.
    Thromb Haemost; 2013 Feb 01; 109(2):221-8. PubMed ID: 23238100
    [Abstract] [Full Text] [Related]

  • 38. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M.
    Blood Coagul Fibrinolysis; 1999 Mar 01; 10(2):93-9. PubMed ID: 10192658
    [Abstract] [Full Text] [Related]

  • 39. Fibrinogen Nijmegen: congenital dysfibrinogenemia associated with impaired t-PA mediated plasminogen activation and decreased binding of t-PA.
    Engesser L, Koopman J, de Munk G, Haverkate F, Nováková I, Verheijen JH, Briët E, Brommer EJ.
    Thromb Haemost; 1988 Aug 30; 60(1):113-20. PubMed ID: 3142089
    [Abstract] [Full Text] [Related]

  • 40. A hereditary dysfibrinogenemia: fibrinogen Awaji.
    Matsuo T, Okuno S, Mukaida T, Ueshima S, Okada K, Matsuo O.
    Haemostasis; 1987 Aug 30; 17(1-2):89-97. PubMed ID: 3596361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.